MTOR - EGLN2

SSL interaction

Gene Name	Gene ID	Diseases	Drugs	GO terms	Orthologs
MTOR	ENSG00000198793	endometrial carcinoma head and neck clear cell renal cell carcinoma anaplastic thyroid cancer urothelial cell carcinoma central nervous system tumours testicular germ cell tumours and other tumour types	No drugs in record	RNA polymerase III type 1 promoter DNA binding RNA polymerase III type 2 promoter DNA binding RNA polymerase III type 3 promoter DNA binding TFIIIC-class transcription factor binding protein kinase activity protein serine/threonine kinase activity protein binding ATP binding kinase activity protein kinase binding protein domain specific binding ribosome binding phosphoprotein binding ribonucleoprotein complex binding chromatin DNA binding nucleocytoplasmic transporter activity	TOR2 (S. cerevisiae) Tor (D. melanogaster)
EGLN2	ENSG00000269858	No diseases in record	No drugs in record	protein binding ferrous iron binding oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors oxygen sensor activity L-ascorbic acid binding peptidyl-proline 4-dioxygenase activity	egl-9 (C. elegans)